Trial intelligence / Profile preview

PK of Atorvastatin in Myotoxicity

NCT00120055Phase 4Completed

Sponsor
University of Oslo School of Pharmacy
Start
Feb 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of atorvastatin in hypercholesterolemia, sponsored by University of Oslo School of Pharmacy. Started Feb 2005; status: completed.

02

Drugs

atorvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00120055.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00120055.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call